171 related articles for article (PubMed ID: 12173940)
1. Lipid-free structure and stability of apolipoprotein A-I: probing the central region by mutation.
Gorshkova IN; Liu T; Zannis VI; Atkinson D
Biochemistry; 2002 Aug; 41(33):10529-39. PubMed ID: 12173940
[TBL] [Abstract][Full Text] [Related]
2. Probing the lipid-free structure and stability of apolipoprotein A-I by mutation.
Gorshkova IN; Liadaki K; Gursky O; Atkinson D; Zannis VI
Biochemistry; 2000 Dec; 39(51):15910-9. PubMed ID: 11123918
[TBL] [Abstract][Full Text] [Related]
3. Structure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation.
Gorshkova IN; Liu T; Kan HY; Chroni A; Zannis VI; Atkinson D
Biochemistry; 2006 Jan; 45(4):1242-54. PubMed ID: 16430220
[TBL] [Abstract][Full Text] [Related]
4. Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
Zhu HL; Atkinson D
Biochemistry; 2007 Feb; 46(6):1624-34. PubMed ID: 17279626
[TBL] [Abstract][Full Text] [Related]
5. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions.
Rogers DP; Roberts LM; Lebowitz J; Datta G; Anantharamaiah GM; Engler JA; Brouillette CG
Biochemistry; 1998 Aug; 37(34):11714-25. PubMed ID: 9718294
[TBL] [Abstract][Full Text] [Related]
6. Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants.
Fang Y; Gursky O; Atkinson D
Biochemistry; 2003 Nov; 42(45):13260-8. PubMed ID: 14609337
[TBL] [Abstract][Full Text] [Related]
7. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
Zhu HL; Atkinson D
Biochemistry; 2004 Oct; 43(41):13156-64. PubMed ID: 15476409
[TBL] [Abstract][Full Text] [Related]
8. Deletion of central alpha-helices in human apolipoprotein A-I: effect on phospholipid association.
Frank PG; Bergeron J; Emmanuel F; Lavigne JP; Sparks DL; Denèfle P; Rassart E; Marcel YL
Biochemistry; 1997 Feb; 36(7):1798-806. PubMed ID: 9048564
[TBL] [Abstract][Full Text] [Related]
9. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
Cho KH; Durbin DM; Jonas A
J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
[TBL] [Abstract][Full Text] [Related]
10. Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1.
Chroni A; Liu T; Fitzgerald ML; Freeman MW; Zannis VI
Biochemistry; 2004 Feb; 43(7):2126-39. PubMed ID: 14967052
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins.
Jonas A; Wald JH; Toohill KL; Krul ES; Kézdy KE
J Biol Chem; 1990 Dec; 265(36):22123-9. PubMed ID: 2125044
[TBL] [Abstract][Full Text] [Related]
12. The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles.
Sparks DL; Lund-Katz S; Phillips MC
J Biol Chem; 1992 Dec; 267(36):25839-47. PubMed ID: 1464598
[TBL] [Abstract][Full Text] [Related]
13. Combined N- and C-terminal truncation of human apolipoprotein A-I yields a folded, functional central domain.
Beckstead JA; Block BL; Bielicki JK; Kay CM; Oda MN; Ryan RO
Biochemistry; 2005 Mar; 44(11):4591-9. PubMed ID: 15766290
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the C-terminal helix by single amino acid deletion is directly responsible for impaired cholesterol efflux ability of apolipoprotein A-I Nichinan.
Kono M; Tanaka T; Tanaka M; Vedhachalam C; Chetty PS; Nguyen D; Dhanasekaran P; Lund-Katz S; Phillips MC; Saito H
J Lipid Res; 2010 Apr; 51(4):809-18. PubMed ID: 19805625
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
[TBL] [Abstract][Full Text] [Related]
16. Characterization of apolipoprotein A-I structure using a cysteine-specific fluorescence probe.
Tricerri MA; Behling Agree AK; Sanchez SA; Jonas A
Biochemistry; 2000 Nov; 39(47):14682-91. PubMed ID: 11087425
[TBL] [Abstract][Full Text] [Related]
17. Deletion of single amino acid E235 affects the structure and lipid interaction of human apolipoprotein A-I C-terminal peptides.
Tanaka T; Tanaka M; Sugiura M; Kawakami T; Aimoto S; Saito H
Chem Pharm Bull (Tokyo); 2009 May; 57(5):499-503. PubMed ID: 19420782
[TBL] [Abstract][Full Text] [Related]
18. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.
Mishra VK; Palgunachari MN; Datta G; Phillips MC; Lund-Katz S; Adeyeye SO; Segrest JP; Anantharamaiah GM
Biochemistry; 1998 Jul; 37(28):10313-24. PubMed ID: 9665740
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of apolipoprotein A-I: effects of amino- and carboxy-terminal deletions on the lipid-free structure.
Rogers DP; Roberts LM; Lebowitz J; Engler JA; Brouillette CG
Biochemistry; 1998 Jan; 37(3):945-55. PubMed ID: 9454585
[TBL] [Abstract][Full Text] [Related]
20. Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids.
Vanloo B; Demoor L; Boutillon C; Lins L; Brasseur R; Baert J; Fruchart JC; Tartar A; Rosseneu M
J Lipid Res; 1995 Aug; 36(8):1686-96. PubMed ID: 7595090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
